Strides Pharma Science Ltd Quarterly Results

Gross Sales

1,220.83

1,119.74

1,190.39

1,153.67

1,166.93

Excise Duty

0

0

0

0

0

Net Sales

1,220.83

1,119.74

1,190.39

1,153.67

1,166.93

Other Operating Income

0

0

0

0

0

Other Income

27.14

8.68

15.11

6.57

28.41

Total Income

1,247.97

1,128.42

1,205.5

1,160.24

1,195.35

Total Expenditure

999.08

910.03

999.94

945.78

986.86

PBIDT

248.89

218.39

205.56

214.45

208.49

Interest

46.13

47.46

50.32

52.18

73.82

PBDT

202.76

170.93

155.24

162.27

134.66

Depreciation

49.64

48.89

48.86

48.42

48.45

Minority Interest Before NP

0

0

0

0

0

Tax

22.74

10.88

4.57

11.66

15.15

Deferred Tax

-1.15

5.57

16.19

12.14

-1.21

Reported Profit After Tax

131.52

105.59

85.62

90.04

72.27

Minority Interest After NP

3.99

5.99

3.42

2.09

0.43

Net Profit after Minority Interest

127.53

99.61

82.19

87.95

71.84

Extra-ordinary Items

-7.47

-7.24

-22.07

-1.92

-3.19

Adjusted Profit After Extra-ordinary item

135

106.85

104.26

89.87

75.03

EPS (Unit Curr.)

13.84

10.81

8.92

9.56

7.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

92.17

92.16

92.16

92.16

91.96

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.38

19.5

17.26

18.58

17.86

PBDTM(%)

16.6

15.26

13.04

14.06

11.53

PATM(%)

10.77

9.42

7.19

7.8

6.19